[Carbohydrate metabolism in patients with chronic pyoderma and its dynamics during therapy using sugar-decreasing preparations].
Carbohydrate metabolism has been examined in 301 patients with chronic pyoderma over the course of combined therapy including sugar-reducing drugs; biochemical methods (measurement of the blood sugar on an empty stomach, Staub-Traugott double carbohydrate load test, measurement of the blood serum seromucoid) and radioimmunoassay of the blood serum immunoreactive insulin have been employed. Diabetes mellitus has been first diagnosed in 2.9% of patients, latent diabetes in 18.8%, and in 4.7% of the examinees the parameters indicate the risk of this condition development. Combined therapy improves the examined parameters, providing good immediate and late results. These data favor the use of sugar-reducing agents in multiple-modality therapy of patients with chronic pyoderma.
Bukharovich
A M
AM
D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D050260:Carbohydrate Metabolism; D002908:Chronic Disease; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000378:metabolism; D004359:Drug Therapy, Combination; D005215:Fasting; D005260:Female; D006029:Glycosuria / Q000652:urine; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011711:Pyoderma / Q000188:drug therapy / Q000378:metabolism*
D001786:Blood Glucose; D007004:Hypoglycemic Agents
Sostoianie uglevodnogo obmena u bol'nykh khronicheskoĭ piodermieĭ i ego dinamika v protsesse terapii s primeneniem sakharoponizhaiushchikh preparatov.